Watz R, Savidge G F
Acta Med Scand. 1979;205(4):293-8. doi: 10.1111/j.0954-6820.1979.tb06050.x.
The results of streptokinase and heparin treatment are compared in a 4-year prospective study with special reference to preservation of high valvular venous function. An objective assessment was based upon phlebographic examinations before, during and 1-2 months after therapy. Complete lysis was demonstrated in 44% of high thromboses treated with streptokinase and in 6% treated with heparin. Retrograde phlebography revealed normal function of the proximal femoral valves in 92% of streptokinase-treated high thromboses, compared with 13% of those treated with heparin. These phlebographic results were considered to be a valid prognostic indicator of the eventual development of the postthrombotic syndrome. Allergic reactions were seen in 39% and minor haemorrhagic complications in 18% of the streptokinase-treated cases. The therapeutic benefit of streptokinase therapy in this study was found to outweigh any disadvantages incurred by observed complications.
在一项为期4年的前瞻性研究中,对链激酶和肝素治疗的结果进行了比较,特别参考了高瓣膜静脉功能的保留情况。客观评估基于治疗前、治疗期间以及治疗后1 - 2个月的静脉造影检查。在用链激酶治疗的高血栓病例中,44%出现完全溶解,而用肝素治疗的病例中这一比例为6%。逆行静脉造影显示,在接受链激酶治疗的高血栓病例中,92%的股静脉近端瓣膜功能正常,相比之下,接受肝素治疗的病例中这一比例为13%。这些静脉造影结果被认为是血栓形成后综合征最终发展的有效预后指标。在接受链激酶治疗的病例中,39%出现过敏反应,18%出现轻微出血并发症。在本研究中,发现链激酶治疗的治疗益处超过了观察到的并发症所带来的任何不利影响。